Authors:
Gougeon, ML
Rouzioux, C
Liberman, I
Burgard, M
Taoufik, Y
Viard, JP
Bouchenafa, K
Capitant, C
Delfraissy, JF
Levy, Y
Citation: Ml. Gougeon et al., Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients, AIDS, 15(13), 2001, pp. 1729-1731
Authors:
Bocchino, M
Ledru, E
Debord, T
Gougeon, ML
Citation: M. Bocchino et al., Increased priming for interleukin-12 and tumour necrosis factor alpha in CD64 monocytes in HIV infection: modulation by cytokines and therapy, AIDS, 15(10), 2001, pp. 1213-1223
Citation: H. Lecoeur et al., Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: A reconsideration of the specificity of the annexin V/Propidium iodide assay, CYTOMETRY, 44(1), 2001, pp. 65-72
Authors:
Lecoeur, H
Fevrier, M
Garcia, S
Riviere, Y
Gougeon, ML
Citation: H. Lecoeur et al., A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity, J IMMUNOL M, 253(1-2), 2001, pp. 177-187
Authors:
Chami, M
Gozuacik, D
Lagorce, D
Brini, M
Falson, P
Peaucellier, G
Pinton, P
Lecoeur, H
Gougeon, ML
le Maire, M
Rizzuto, R
Brechot, C
Paterlini-Brechot, P
Citation: M. Chami et al., SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis, J CELL BIOL, 153(6), 2001, pp. 1301-1313
Authors:
Fellay, B
Chofflon, M
Juillard, C
Paunier, AM
Landis, T
Roth, S
Gougeon, ML
Citation: B. Fellay et al., Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells inmultiple sclerosis, IMMUNOLOGY, 104(4), 2001, pp. 383-391
Authors:
Chami, M
Gozuacik, D
Saigo, K
Capiod, T
Falson, P
Lecoeur, H
Urashima, T
Beckmann, J
Gougeon, ML
Claret, M
le Maire, M
Brechot, C
Paterlini-Brechot, P
Citation: M. Chami et al., Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis, ONCOGENE, 19(25), 2000, pp. 2877-2886
Citation: Ml. Gougeon et al., Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors, SPR SEM IMM, 22(3), 2000, pp. 251-263
Authors:
Malkovsky, M
Wallace, M
Fournie, JJ
Fisch, P
Poccia, F
Gougeon, ML
Citation: M. Malkovsky et al., Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gamma delta T lymphocytes and natural killer cells, AIDS, 14, 2000, pp. S175-S186
Authors:
Michel, P
Balde, AT
Roussilhon, C
Aribot, G
Sarthou, JL
Gougeon, ML
Citation: P. Michel et al., Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: Correlation of T cell apoptosis with beta(2) microglobulin concentration and disease evolution, J INFEC DIS, 181(1), 2000, pp. 64-75
Authors:
Ledru, E
Christeff, N
Patey, O
de Truchis, P
Melchior, JC
Gougeon, ML
Citation: E. Ledru et al., Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome, BLOOD, 95(10), 2000, pp. 3191-3198
Citation: H. Naora et Ml. Gougeon, Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression, CELL DEAT D, 6(10), 1999, pp. 1002-1011
Authors:
Brown, L
Souberbielle, BE
Marriott, JB
Westby, M
Desselberger, U
Kaye, T
Gougeon, ML
Dalgleish, A
Citation: L. Brown et al., The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed people, AIDS, 13(18), 1999, pp. 2515-2521
Authors:
Christeff, N
Melchior, JC
de Truchis, P
Perronne, C
Nunez, EA
Gougeon, ML
Citation: N. Christeff et al., Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations, AIDS, 13(16), 1999, pp. 2251-2260
Citation: H. Naora et Ml. Gougeon, Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15, IMMUNOL LET, 68(2-3), 1999, pp. 359-367
Citation: Ml. Gougeon et al., Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART), IMMUNOL LET, 66(1-3), 1999, pp. 97-103
Authors:
Poccia, F
Battistini, L
Cipriani, B
Mancino, G
Martini, F
Gougeon, ML
Colizzi, V
Citation: F. Poccia et al., Phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes suppress in vitrohuman immunodeficiency virus type 1 replication by cell-released antiviralfactors including CC chemokines, J INFEC DIS, 180(3), 1999, pp. 858-861
Citation: H. Naora et Ml. Gougeon, Activation, survival and apoptosis of CD45RO(+) and CD45RO(-) T cells of human immunodeficiency virus-infected individuals: effects of interleukin-15and comparison with interleukin-2, IMMUNOLOGY, 97(2), 1999, pp. 181-187
Authors:
Boullier, S
Poquet, Y
Debord, T
Fournie, JJ
Gougeon, ML
Citation: S. Boullier et al., Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the V gamma 9V delta 2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons, EUR J IMMUN, 29(1), 1999, pp. 90-99